New England Asset Management Inc Elanco Animal Health Inc Transaction History

New England Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$21.1 - $29.13 $14,263 - $19,691	-676 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$16.68 - $32.25 $1.02 Million - $1.98 Million	-61,400 Reduced 98.91%	676 $15,000
Q4 2019 Feb 14, 2020	BUY	$25.29 - $29.45 $308,538 - $359,290	12,200 Added 24.46%	62,076 $1.83 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $896,932 - $1 Million	-28,831 Reduced 36.63%	49,876 $1.69 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $1.96 Million - $2.22 Million	67,507 Added 602.74%	78,707 $2.52 Million
Q4 2018 Feb 14, 2019	SELL	$29.63 - $34.5 $314,078 - $365,700	-10,600 Reduced 48.62%	11,200 $353,000
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $743,380 - $788,942	21,800 New	21,800 $761,000

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on New England Asset Management Inc with notifications on news.